LeMaitre Vascular (LMAT) Earnings Analysis
LeMaitre Vascular (LMAT) has no confirmed upcoming earnings date. Last quarter (2025-11-06) it beat with EPS 0.62 USD vs 0.564 USD est (+9.9%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 35.80.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LMAT next report earnings?
No confirmed upcoming earnings date is currently scheduled for LMAT. This page updates as the calendar is published.
LMAT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-11-06 | 0.62 USD | 0.564 USD | +9.9% | Beat |
| 2025-05-01 | 0.48 USD | 0.5 USD | -4% | Miss |
| 2025-02-27 | 0.49 USD | 0.49 USD | 0% | Beat |
| 2024-10-31 | 0.49 USD | 0.44 USD | +11.4% | Beat |
| 2024-08-01 | 0.52 USD | 0.47 USD | +10.6% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
LMAT valuation and analyst view
| Trailing P/E | 35.80 |
|---|---|
| Trailing EPS | 2.737 USD |
| Price / book | 5.54 |
| Dividend yield | 0.91% |
| Market cap | 2.26B |
| Analyst consensus | Buy (14 buy / 6 hold / 0 sell) |
| Avg price target | 127.5 USD |
Related research pages
Frequently asked questions
When is LeMaitre Vascular (LMAT)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for LMAT. This page updates as the calendar is published.
Did LMAT beat earnings last quarter?
In its 2025-11-06 report, LMAT posted EPS of 0.62 USD versus a 0.564 USD estimate — a beat of 9.9%.
What is LMAT's earnings track record?
Over the last 5 reported quarters with consensus data, LMAT beat estimates 4 times (80%).
What is LMAT's current P/E ratio and EPS?
LMAT trades at a trailing P/E of 35.80 on trailing EPS of 2.73680978904434 USD.
What do analysts rate LMAT?
Analyst consensus is "Buy" across 20 ratings (0 strong buy, 14 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 127.5 USD.